Qualitative Analysis of Hydroxyurea

Qualitative Analysis of Hydroxyurea

Show other versions (3)

Hydroxyurea (HU) is a cytostatic agent with antineoplastic activity and it has great clinical efficacy in the treatment of sickle cell disease. HU is part of the National Relation of Essential Medicines of Brazil and despite of its clinical importance, only the Portuguese, American and European Phar...

Full description

Bibliographic Details
Main Authors:	Stéfanno Souza Santos, Isis Gomes dos Santos, Cinara Vanconcelos da Silva, Edith C L Cazedey
Format:	Article
Language:	English
Published:	Universidade Federal do Rio Grande do Sul 2020-07-01
Series:	Drug Analytical Research
Online Access:	https://seer.ufrgs.br/index.php/dar/article/view/100682

Similar Items

Qualitative Analysis of Hydroxyurea
by: Stéfanno Souza Santos, et al.
Published: (2020-07-01)

Qualitative Analysis of Hydroxyurea
by: Stéfanno Souza Santos, et al.
Published: (2020-07-01)

Qualitative Analysis of Hydroxyurea
by: Stéfanno Souza Santos, et al.
Published: (2020-07-01)

Evaluation of hydroxyurea genotoxicity in patients with sickle cell disease
by: Emanuel Almeida Moreira de Oliveira, et al.

The burden and quality of life of caregivers of sickle cell anemia patients taking hydroxyurea versus those not taking hydroxyurea
by: Luiz Bernardino Lima da Silva, et al.
Published: (2012-01-01)

Hydroxyurea-induced melanonychia
by: Michael G. Buontempo, BS, et al.
Published: (2023-12-01)

Hydroxyurea—The Good, the Bad and the Ugly
by: Marcelina W. Musiałek, et al.
Published: (2021-07-01)

Hydroxyurea-induced Tooth Discoloration
by: Muhammed Okuyucu, et al.
Published: (2020-02-01)

Blue Lunula Related with Hydroxyurea
by: Hava Üsküdar Teke, et al.
Published: (2013-03-01)

Adherence to Hydroxyurea and Patients’ Perceptions of Sickle Cell Disease and Hydroxyurea: A Cross-Sectional Study
by: Mohammed Ali Madkhali, et al.
Published: (2024-01-01)

Methemoglobin measure in adult patients with sickle-cell anemia: influence of hydroxyurea therapy
by: Marilia Rocha Laurentino, et al.
Published: (2014-06-01)

Patients with sickle cell disease taking hydroxyurea in the Hemocentro Regional de Montes Claros
by: Fernanda Kelle de Souza Santos, et al.
Published: (2011-01-01)

The influence of hydroxyurea on oxidative stress in sickle cell anemia
by: Lidiane de Souza Torres, et al.
Published: (2012-01-01)

The influence of hydroxyurea on oxidative stress in sickle cell anemia
by: Lidiane de Souza Torres, et al.
Published: (2012-01-01)

P-048: INFLUENCE OF SEVEN GENETIC POLYMORPHISMS ON THE RESPONSE TO SICKLE CELL DISEASE THERAPY WITH HYDROXYUREA
by: FRANCO SANTOS O., et al.
Published: (2022-08-01)

Effectiveness of Pharmacokinetic-Guided Hydroxyurea Dose Individualization in Patients with Sickle Cell Anemia: A Mini-Review
by: Joelma Santana dos Santos Neres, et al.
Published: (2023-06-01)

The Role of Hydroxyurea on Growth in Children with SCD
by: Zahrah Mohammed Alkashi
Published: (2023-01-01)

The Use of Hydroxyurea in the Treatment of COVID-19
by: Foster Melissa Robin Bowman, et al.
Published: (2021-10-01)

Oral lesions associated with hydroxyurea treatment
by: Regina Mendonça, et al.
Published: (2011-01-01)

Biochemical Evaluation of the Effects of Hydroxyurea in Vitro on Red Blood Cells
by: Cristiane Oliveira Renó, et al.
Published: (2021-10-01)

Minimal doses of hydroxyurea for sickle cell disease
by: C.S.P. Lima, et al.
Published: (1997-08-01)

PI-03: THE EFFECT OF HYDROXYUREA IN THE GUT MICROBIOME OF ANGOLAN CHILDREN WITH SICKLE CELL DISEASE
by: DELGADINHO M., et al.
Published: (2022-08-01)

5595849 THE GUT MICROBIOME AND HYDROXYUREA EFFECT ON SICKLE CELL DISEASE CHILDREN FROM ANGOLA
by: M. Brito, et al.
Published: (2023-04-01)

Role of Hydroxyurea in Patients of Beta Thalassemia Majo
by: Benish Fatima, et al.
Published: (2022-12-01)

Phases of crown-gall transformation susceptible to hydroxyurea
by: Aldona Rennert, et al.
Published: (2014-01-01)

Leg ulcer with long‐term hydroxyurea use
by: Mohammad Ammad Ud Din, et al.
Published: (2021-04-01)

Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia.
by: Harrison, C, et al.
Published: (2005)

Cytotoxicity and DNA damage in the neutrophils of patients with sickle cell anaemia treated with hydroxyurea
by: Alano Martins Pedrosa, et al.
Published: (2014-04-01)

Analysis of the Involvement of Different Ceramide Variants in the Response to Hydroxyurea Stress in Baker's Yeast.
by: Po-Wei Chen, et al.
Published: (2016-01-01)

Development and Validation of a Microbiological Agar Assay for Determination of Orbifloxacin in Pharmaceutical Preparations
by: Hérida R. N. Salgado, et al.
Published: (2011-08-01)

Barriers and Facilitators of Availability of Hydroxyurea for Sickle Cell Disease in Tanzania; A Qualitative Study of Pharmaceutical Manufacturers, Importers, and Regulators
by: Hamu J. Mlyuka, et al.
Published: (2022-11-01)

P-009: IDENTIFYING BARRIERS FOR PATIENTS WITH SICKLE CELL DISEASE TO ACCESS TREATMENT WITH HYDROXYUREA – A QUALITATIVE ANALYSIS OF THE SUPPLY CHAIN IN GHANA
by: GRAVEN S., et al.
Published: (2022-08-01)

Genome instability footprint under rapamycin and hydroxyurea treatments.
by: Jing Li, et al.
Published: (2023-11-01)

Resumption of Spermatogenesis and Fertility Post Withdrawal of Hydroxyurea Treatment
by: Carlos Virgous, et al.
Published: (2023-05-01)

Hydroxyurea pharmacokinetics and precision dosing in low-resource settings
by: Luke R. Smart, et al.
Published: (2023-06-01)

Hydroxyurea treatment inhibits proliferation of Cryptococcus neoformans in mice
by: Kaushlendra eTripathi, et al.
Published: (2012-05-01)

Hydroxyurea for sickle-cell anaemia in Africa: mind the gap
by: Stephen K Obaro
Published: (2015-03-01)

Hydroxyurea and sickle cell anemia: effect on quality of life
by: Pegelow Charles H, et al.
Published: (2006-08-01)

Hydroxyurea granules for the management of sickle cell disease in children
by: Grace Lovia Allotey-Babington, et al.
Published: (2022-07-01)

Hydroxyurea-Mediated Cytotoxicity Without Inhibition of Ribonucleotide Reductase
by: Li Phing Liew, et al.
Published: (2016-11-01)